(VIANEWS) – Halozyme Therapeutics (HALO), Progyny (PGNY), MainStreet Bancshares (MNSB) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Halozyme Therapeutics (HALO)
30.7% sales growth and 110.23% return on equity
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. Its flagship product is Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in subcutaneous urography and to improve resorption of radiopaque agents. The company also develops Perjeta; RITUXAN HYCELA and MabThera SC for the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia (CLL); RITUXAN SC for patients with CLL; and HYQVIA for the treatment of immunodeficiency disorders. In addition, it is developing Tecentriq for non-small cell lung cancer; OCREVUS for multiple sclerosis; DARZALEX for the treatment of patients with amyloidosis, smoldering myeloma, and multiple myeloma; nivolumab for the treatment of solid tumors; ARGX-113, a human neonatal Fc receptor; ARGX-117 to treat autoimmune diseases; and BMS-986179, an anti-CD-73 antibody. The company has collaborations with F. Hoffmann-La Roche, Ltd.; Hoffmann-La Roche, Inc.; Baxalta US Inc.; Baxalta GmbH; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; Alexion Pharma Holding; ARGENX BVBA; Horizon Therapeutics plc; National Institute of Allergy and Infectious Diseases; Centre for the AIDS Programme of Research in South Africa; and ViiV Healthcare Limited for small and large molecule targets for the treatment and prevention of HIV. Halozyme Therapeutics, Inc. was founded in 1998 and is based in San Diego, California.
Earnings Per Share
As for profitability, Halozyme Therapeutics has a trailing twelve months EPS of $1.42.
PE Ratio
Halozyme Therapeutics has a trailing twelve months price to earnings ratio of 23.87. Meaning, the purchaser of the share is investing $23.87 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 110.23%.
2. Progyny (PGNY)
29.9% sales growth and 9.66% return on equity
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Progyny has a trailing twelve months EPS of $0.31.
PE Ratio
Progyny has a trailing twelve months price to earnings ratio of 107.23. Meaning, the purchaser of the share is investing $107.23 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.66%.
3. MainStreet Bancshares (MNSB)
27.7% sales growth and 14.93% return on equity
MainStreet Bancshares, Inc. operates as the bank holding company for MainStreet Bank that provides various banking products and services for individuals, small to medium-sized businesses, and professional service organizations primarily in Northern Virginia and the greater Washington, the District of Columbia metropolitan area. The company offers demand, NOW, money market, savings, and sweep accounts, as well as certificates of deposit; business and consumer checking, interest-bearing checking, business account analysis, and other depository services; and cash management, wire transfer, check imaging, remote deposit capture, and courier services. It also provides commercial loans, including government contract receivables, plant and equipment, general working capital, contract administration, and acquisition loans; commercial real estate, real estate construction, and residential real estate loans; and consumer loans comprising car loans, term loans, credit cards, and overdraft protection. In addition, the company provides payment service and deposit insurance solutions; remote deposit of checks; and internet bill payment, online cash management, and online and mobile banking services. It operates through a network of seven branches located in Herndon, Fairfax, Fairfax City, McLean, Clarendon, and Leesburg, Virginia, and one branch in Washington, the District of Columbia; and provides automated teller machine transaction services at approximately 55,000 locations in the United States, Canada, the United Kingdom, and Mexico. MainStreet Bancshares, Inc. was incorporated in 2003 and is headquartered in Fairfax, Virginia.
Earnings Per Share
As for profitability, MainStreet Bancshares has a trailing twelve months EPS of $3.72.
PE Ratio
MainStreet Bancshares has a trailing twelve months price to earnings ratio of 5.71. Meaning, the purchaser of the share is investing $5.71 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.93%.
Sales Growth
MainStreet Bancshares’s sales growth is 35.8% for the current quarter and 27.7% for the next.
Yearly Top and Bottom Value
MainStreet Bancshares’s stock is valued at $21.23 at 06:23 EST, way under its 52-week high of $30.98 and above its 52-week low of $20.37.
4. Travelzoo (TZOO)
22.7% sales growth and 145.09% return on equity
Travelzoo, an Internet media company, provides travel, entertainment, and local deals from travel and entertainment companies, and local businesses in the Asia Pacific, Europe, and North America. Its publications and products include Travelzoo Website; Travelzoo iPhone and Android apps; Travelzoo Top 20 email newsletter; and Newsflash email alert service. The company also operates the Travelzoo Network, a network of third-party Websites that list travel deals published by the company; and Local Deals and Getaway listings, which allow its members to purchase vouchers for deals from local businesses, such as spas, hotels, and restaurants. It serves airlines, hotels, cruise lines, vacations packagers, tour operators, destinations, car rental companies, travel agents, theater and performing arts groups, restaurants, spas, and activity companies. Travelzoo Inc. was founded in 1998 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Travelzoo has a trailing twelve months EPS of $0.53.
PE Ratio
Travelzoo has a trailing twelve months price to earnings ratio of 10.96. Meaning, the purchaser of the share is investing $10.96 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 145.09%.
Volume
Today’s last reported volume for Travelzoo is 80272 which is 56.74% above its average volume of 51213.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 15.8% and positive 187.5% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Travelzoo’s EBITDA is 11.1.
5. First Community Bankshares (FCBC)
15.8% sales growth and 10.98% return on equity
First Community Bankshares, Inc. operates as the financial holding company for First Community Bank that provides various banking products and services. It offers demand deposit accounts, savings and money market accounts, certificates of deposit, and individual retirement arrangements; commercial, consumer, and real estate mortgage loans, as well as lines of credit; various credit and debit cards, and automated teller machine card services; and corporate and personal trust services. The company also provides wealth management services, including trust management, estate administration, and investment advisory services; and investment management services. It serves individuals and businesses across various industries, such as education, government, and health services; coal mining and gas extraction; retail trade; construction; manufacturing; tourism; and transportation. As of December 31, 2021, the company operated 49 branches, including 17 branches in West Virginia, 23 branches in Virginia, 7 branches in North Carolina, and 2 branches in Tennessee. First Community Bankshares, Inc. was founded in 1874 and is headquartered in Bluefield, Virginia.
Earnings Per Share
As for profitability, First Community Bankshares has a trailing twelve months EPS of $2.82.
PE Ratio
First Community Bankshares has a trailing twelve months price to earnings ratio of 8.62. Meaning, the purchaser of the share is investing $8.62 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.98%.
Sales Growth
First Community Bankshares’s sales growth is 7.3% for the ongoing quarter and 15.8% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 3.1%, now sitting on 143.27M for the twelve trailing months.
6. Entergy Louisiana, LLC First Mortgage Bonds, 5.875% (ELA)
14% sales growth and 44.23% return on equity
Envela Corporation, together with its subsidiaries, primarily buys and sells jewelry and bullion products to individual consumers, dealers, Fortune 500 companies, municipalities, school districts, and other organizations in the United States. It offers jewelry and fine-watch products, including bridal jewelry, fashion jewelry, custom-made jewelry, diamonds, and other gemstones, as well as watches and jewelry components. The company also buys and sells various forms of gold, silver, platinum, and palladium products, including United States and other government coins, private mint medallions, art bars, and trade unit bars; and numismatic items, such as rare coins, currency, medals, tokens, and other collectibles, as well as provides jewelry and watches repair services. In addition, it offers end-of-life electronics recycling services; disposal transportation and product tracking services; IT-asset disposition services, including compliance and data sanitization services; and services to companies in the areas of software upgrades, and hardware or networking capabilities, as well as moving to cloud services. As of December 31, 2021, Envela Corporation marketed its products and services through six retail locations under the Dallas Gold & Silver Exchange name; and one retail location under the Charleston Gold & Diamond Exchange name, as well as through cgdeinc.com, dgse.com, echoenvironmental.com, ITADUSA.com, availrecovery.com, and teladvance.com e-commerce sites. The company was formerly known as DGSE Companies, Inc. and changed its name to Envela Corporation in December 2019. Envela Corporation was incorporated in 1965 and is headquartered in Irving, Texas.
Earnings Per Share
As for profitability, Entergy Louisiana, LLC First Mortgage Bonds, 5.875% has a trailing twelve months EPS of $0.59.
PE Ratio
Entergy Louisiana, LLC First Mortgage Bonds, 5.875% has a trailing twelve months price to earnings ratio of 10.39. Meaning, the purchaser of the share is investing $10.39 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 44.23%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Entergy Louisiana, LLC First Mortgage Bonds, 5.875%’s EBITDA is 30.57.
7. AMETEK (AME)
5.4% sales growth and 16.16% return on equity
AMETEK, Inc. manufactures and sells electronic instruments and electromechanical devices in North America, Europe, Asia, and South America. It operates in two segments, Electronic Instruments (EIG) and Electromechanical (EMG). The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets.Its EMG segment offers engineered electrical connectors and electronics packaging to protect sensitive devices and mission-critical electronics; precision motion control products for data storage, medical devices, business equipment, automation, and other applications; high-purity powdered metals, strips and foils, specialty clad metals, and metal matrix composites; motor-blower systems and heat exchangers for use in thermal management, military, commercial aircraft, and military ground vehicles; and motors for use in commercial appliances, fitness equipment, food and beverage machines, hydraulic pumps, and industrial blowers. This segment also operates a network of aviation maintenance, repair, and overhaul facilities. In addition, the company offers clinical and educational communication solutions. AMETEK, Inc. was incorporated in 1930 and is headquartered in Berwyn, Pennsylvania.
Earnings Per Share
As for profitability, AMETEK has a trailing twelve months EPS of $5.02.
PE Ratio
AMETEK has a trailing twelve months price to earnings ratio of 28.85. Meaning, the purchaser of the share is investing $28.85 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.16%.
Previous days news about AMETEK(AME)
- Ametek (ame) Q1 earnings & sales surpass estimates, up y/y. According to Zacks on Tuesday, 2 May, "The AMETEK Growth Model is likely to continue driving AME’s business performance.", "EIG (70% of total sales): AMETEK generated sales of $1.12 billion from the segment, reflecting growth of 13% from the year-ago quarter.EMG (30% of sales): The segment generated $479.9 million in sales in the first quarter, which improved by 2% on a year-over-year basis."
8. HCA Holdings (HCA)
5.1% sales growth and 2139.94% return on equity
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Earnings Per Share
As for profitability, HCA Holdings has a trailing twelve months EPS of $19.85.
PE Ratio
HCA Holdings has a trailing twelve months price to earnings ratio of 14.11. Meaning, the purchaser of the share is investing $14.11 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2139.94%.
